A. Lonnebo et al., AN ASSESSMENT OF THE SYSTEMIC EFFECTS OF SINGLE AND REPEATED DOSES OFINHALED FLUTICASONE PROPIONATE AND INHALED BUDESONIDE IN HEALTHY-VOLUNTEERS, European Journal of Clinical Pharmacology, 49(6), 1996, pp. 459-463
The systemic effects of single and multiple doses of inhaled fluticaso
ne propionate (FP) and budesonide were examined in 24 healthy male vol
unteers (age range 18-29 years). The study was of an open, placebo-con
trolled, randomized, three-way crossover design. On each study day, mu
ltiple blood samples were taken over a 20 h period after drug administ
ration (after a single dose and after the last of seven doses) and are
a under- the curve (AUC(0-20)) for plasma cortisol and white blood cel
l (WBC) counts was calculated. Results: The present study shows that m
ultiple dosing with FP 1.0 mg b.i.d. for 3.5 days (seven doses) result
ed in a marked cortisol suppression from placebo which, at 55%, was mo
re than double that seen with a single dose (25% suppression). Multipl
e dosing with budesonide 0.8 mg b.i.d. resulted in a 34% suppression i
n plasma cortisol compared with a suppression of 26% with a single dos
e. The increase in systemic activity of FP after multiple dosing is co
nfirmed by both the number of subjects with 0800 hours plasma cortisol
values below normal limits and by the changes in WBC and differential
counts. Conclusion: The results of the present study confirm previous
findings with regard to the more marked systemic effect of FP followi
ng multiple dosing as compared with a single dose. This increase in sy
stemic effect from single dosing to multiple dosing is significantly g
reater for FP than for budesonide.